{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:27:38Z","timestamp":1787113658619,"version":"build-2736575974"},"reference-count":36,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: The C-reactive protein-to-albumin ratio (CAR) is an emerging biomarker of disease activity in adult inflammatory bowel disease; pediatric data remain limited. We evaluated CAR in pediatric Crohn\u2019s disease (CD) versus ulcerative colitis (UC). Methods: We retrospectively reviewed 97 consecutive pediatric patients (79 CD, 18 UC) diagnosed at a single center between 2012 and 2023. Results: CAR was higher in CD (median 10.06) than UC (0.49; p &lt; 0.001). In CD, CAR correlated with erythrocyte sedimentation rate, fecal calprotectin, and clinical and endoscopic disease activity (all p &lt; 0.05), differed across severity categories (p = 0.001 clinical, p = 0.003 endoscopic), and was higher without perianal disease (p = 0.005); the corresponding analyses in UC (n = 18) were underpowered and did not reach significance. Receiver operating characteristic analysis yielded an area under the curve (AUC) of 0.840 (cut-off 1.62; sensitivity 86.1%, specificity 72.2%), not exceeding that of CRP alone (AUC 0.851; DeLong p = 0.090). CAR decreased significantly from diagnosis to one-year follow-up in both remission and relapse groups (both p &lt; 0.001). Conclusions: CAR reflects disease severity in pediatric CD and responds to treatment, but did not outperform CRP alone for distinguishing CD from UC. Its plausible value lies in activity assessment and serial monitoring rather than in diagnostic discrimination, a hypothesis that the present design cannot test.<\/jats:p>","DOI":"10.3390\/diagnostics16162608","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:42:17Z","timestamp":1786974137000},"page":"2608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-Reactive Protein-to-Albumin Ratio in Pediatric Inflammatory Bowel Disease: Associations with Disease Activity and Comparison with C-Reactive Protein Alone"],"prefix":"10.3390","volume":"16","author":[{"given":"Jihye","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6839-9244","authenticated-orcid":false,"given":"You Ie","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Incheon St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, 56 Dongsu-ro, Bupyeong-gu, Incheon 21431, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3748\/wjg.v24.i25.2741","article-title":"Current global trends in the incidence of pediatric-onset inflammatory bowel disease","volume":"24","author":"Schwarz","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory bowel disease in children and adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2021.12.282","article-title":"Twenty-first century trends in the global epidemiology of pediatric-onset inflammatory bowel disease: A systematic review","volume":"162","author":"Kuenzig","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/apt.17125","article-title":"Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: A nationwide population-based study","volume":"56","author":"Choe","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2020.07.065","article-title":"Predicting outcomes in pediatric Crohn\u2019s disease for management optimization: Systematic review and consensus statements from the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","article-title":"The medical management of paediatric Crohn\u2019s disease: An ECCO-ESPGHAN guideline update","volume":"15","author":"Aloi","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: Useful, magic, or unnecessary toys?","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7861\/clinmedicine.9-1-30","article-title":"Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein\/albumin ratio as a predictor of patient outcome","volume":"9","author":"Fairclough","year":"2009","journal-title":"Clin. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.12659\/MSM.897460","article-title":"Serum albumin and C-reactive protein\/albumin ratio are useful biomarkers of Crohn\u2019s disease activity","volume":"22","author":"Qin","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e25200","DOI":"10.1097\/MD.0000000000025200","article-title":"Accuracy of the highly sensitive C-reactive protein\/albumin ratio to determine disease activity in inflammatory bowel disease","volume":"100","author":"Liu","year":"2021","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3467419","DOI":"10.1155\/2020\/3467419","article-title":"The relationship between C-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease","volume":"2020","author":"Chen","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_14","first-page":"e937842","article-title":"C-reactive protein\/albumin ratio at diagnosis of pediatric inflammatory bowel disease: A retrospective multi-center study","volume":"28","author":"Szczepanik","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ibd.21493","article-title":"Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification","volume":"17","author":"Levine","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3345\/kjp.2018.61.5.135","article-title":"The 2017 Korean National Growth Charts for children and adolescents: Development, improvement, and prospects","volume":"61","author":"Kim","year":"2018","journal-title":"Korean J. Pediatr."},{"key":"ref_17","first-page":"439","article-title":"Development and validation of a pediatric Crohn\u2019s disease activity index","volume":"12","author":"Hyams","year":"1991","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.gastro.2007.05.029","article-title":"Development, validation, and evaluation of a pediatric ulcerative colitis activity index: A prospective multicenter study","volume":"133","author":"Turner","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn\u2019s disease: The SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest. Endosc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","article-title":"Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: A randomized study","volume":"317","author":"Schroeder","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1002\/jgh3.13059","article-title":"Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel disease","volume":"8","author":"Nguyen","year":"2024","journal-title":"JGH Open"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Li, P., Wu, Y., Xiong, W., Cao, J., Chen, M., Yuan, Z., Guo, W., and Yang, B. (2025). Association between the immune-inflammation index and the severity and clinical outcomes of patients with inflammatory bowel disease: A systematic review and meta-analysis. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-04033-4"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MIB.0000000000000296","article-title":"Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: Influence on phenotype, natural history, and response to therapy","volume":"21","author":"Henderson","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/00365520500217118","article-title":"Clinically active Crohn\u2019s disease in the presence of a low C-reactive protein","volume":"41","author":"Florin","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2011.04.028","article-title":"Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease","volume":"159","author":"Tsampalieros","year":"2011","journal-title":"J. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2468-1253(23)00011-0","article-title":"Inflammation and malnutrition in inflammatory bowel disease","volume":"8","author":"Massironi","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/jgh.16895","article-title":"Review article: Albumin and its role in inflammatory bowel disease: The old, the new, and the future","volume":"40","author":"Cameron","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MEG.0000000000002842","article-title":"The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients","volume":"37","author":"Cesaro","year":"2025","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e207378","DOI":"10.1001\/jamanetworkopen.2020.7378","article-title":"Association between steroid-sparing therapy and the risk of perianal fistulizing complications among young patients with Crohn disease","volume":"3","author":"Adler","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ajg.2011.437","article-title":"Clinical and genetic risk factors for perianal Crohn\u2019s disease in a population-based cohort","volume":"107","author":"Eglinton","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Xu, F., Li, Y., and Chen, B. (2024). C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1349070"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.advms.2018.08.001","article-title":"The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn\u2019s disease","volume":"64","author":"Daniluk","year":"2019","journal-title":"Adv. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/apt.15662","article-title":"Review article: Faecal calprotectin and histologic remission in ulcerative colitis","volume":"51","author":"Bonovas","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, X.F., Huang, Z.M., and Huang, X.L. (2025). Fibrinogen-to-albumin ratio: A new biomarker to identify inflammatory bowel disease in active stage. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1460975"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: An updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/16\/2608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:16:14Z","timestamp":1787112974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/16\/2608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":36,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diagnostics16162608"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16162608","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}